Specific Antirheumatic Agents

Name
Specific Antirheumatic Agents
Accession Number
DBCAT002476
Description

Not Available

ATC Classification
Drugs
DrugDrug Description
PenicillamineA chelator used to treat Wilson's disease, cystinuria, and rheumatoid arthritis.
AuranofinAn antirheumatic used to treat active, progressive, or destructive forms of inflammatory arthritis.
AurothioglucoseA gold compound used in the treatment of rheumatoid arthritis.
Sodium aurothiomalateA disease-modifying antirheumatic drug (DMARD) indicated for the symptomatic treatment of arthritis.
BucillamineBucillamine has been used in trials studying the treatment and prevention of Gout and Rheumatoid Arthritis.
OxycinchophenNot Annotated
Sodium aurotiosulfateNot Annotated
AurotioprolNot Annotated
Drugs & Drug Targets
DrugTargetType
PenicillamineSolute carrier organic anion transporter family member 1B1transporter
PenicillamineCoppertarget
AuranofinInhibitor of nuclear factor kappa-B kinase subunit betatarget
AuranofinSerum albumincarrier
AuranofinPeroxiredoxin-5, mitochondrialtarget
AurothioglucoseAdenylate cyclase type 1target
AurothioglucoseAdenylate cyclase type 2target
AurothioglucoseAdenylate cyclase type 5target
Sodium aurothiomalateUDP-glucuronosyltransferase 1-1enzyme